Side by side
Klowverine vs KPV
Both are discussed for healing & recovery. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.
| Klowverine | KPV | |
|---|---|---|
| What it is | A four-peptide blend of 50 mg GHK-Cu with 20 mg each of BPC-157, TB-500 and KPV, which is KLOW with the three repair peptides doubled. The least documented of the named blends. | A three-amino-acid fragment of alpha-MSH studied for anti-inflammatory effects, largely in animal models of gut inflammation. |
| EvidenceHow much human evidence exists, not how well it works. | Preclinical | Preclinical |
| Regulatory statusReviewed 2026-08-25 | Not approved anywhere as a mixture or as any of its parts. Sold as a research chemical, and less consistently documented than KLOW — the ratio is reported rather than specified. | Not approved for human use in the United States. Sold only as a research chemical. |
| Routes | Subcutaneous | Subcutaneous, Oral, Topical |
| Half-life | Not recorded | 1 hours |
| Cheapest per mgVials only, read from vendors' own listings and dated on the price index. | Not recorded | $1.40/mg |
| Median per mg | Not recorded | $4.50/mg |
| Vendors with a price | Not recorded | 52 |
| Storage once mixed | Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it. | Refrigerated at 2–8 °C. Do not freeze once mixed. |
Compare two other compounds · The full price index
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.